Company Filing History:
Years Active: 2015-2019
Title: Keehoon Jung: An Innovative Mind in Biotechnology
Introduction: Keehoon Jung is a notable inventor based in Seoul, South Korea, who has made significant contributions to the field of biotechnology with a focus on fusion proteins. With two patents to his name, he showcases an innovative approach to addressing complex biological interactions.
Latest Patents: Keehoon Jung's latest patents include groundbreaking work on fusion proteins that bind to key signaling molecules. His first patent involves an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding Vascular Endothelial Growth Factor (VEGF) and Angiopoietin. This invention presents a novel approach that includes a nucleotide sequence encoding both a Tie2 component and a VEGFR component, offering potential advancements in therapeutic applications.
The second patent describes a fusion protein capable of binding VEGF-A and Tumor Necrosis Factor-alpha (TNF-alpha). This application details an isolated nucleic acid molecule encoding a polypeptide that combines the effects of VEGF and TNF, comprising a TNFR2 component linked to a VEGFR1 component, along with a multimerizing component. The specificity of the TNFR2 component and the Ig-like domain of VEGFR1 adds innovative value to this invention.
Career Highlights: Keehoon Jung has worked with leading companies in the biotechnology sector, including Aprogen Inc. and the Korea Advanced Institute of Science and Technology (KAIST). His experience in these reputable organizations has contributed immensely to his development as a leading inventor in his field.
Collaborations: Throughout his career, Keehoon Jung has collaborated with esteemed colleagues, including Young Jun Koh and Gou Young Koh. Their combined expertise highlights the collaborative nature of innovation in biotechnology, fostering advancements that benefit broader research and development initiatives.
Conclusion: Keehoon Jung stands out as an innovative inventor whose work on fusion proteins presents new opportunities for therapeutic development. His dedication and collaboration with notable organizations and colleagues reflect the vibrant and dynamic nature of biotechnology research in South Korea. As he continues to build on his impressive portfolio, Keehoon Jung exemplifies the spirit of innovation that drives the scientific community forward.